A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia

被引：206
|
作者：
Benecke, R
Jost, WH
Kanovsky, P
Ruzicka, E
Comes, G
Grafe, S
机构：
[1] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany
[2] Deutsch Klin Diagnost, Dept Neurol, D-6200 Wiesbaden, Germany
[3] Masaryk Univ, Dept Neurol, Brno, Czech Republic
[4] Charles Univ, Dept Neurol, CR-11636 Prague, Czech Republic
[5] Merz Pharmaceut GmbH, Frankfurt, Germany
来源：
NEUROLOGY | 2005年 / 64卷 / 11期
关键词：
D O I：
10.1212/01.WNL.0000163767.99354.C3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A new botulinum toxin type A free of complexing proteins (NT 201) was compared with BOTOX in patients with cervical dystonia by means of a double-blind noninferiority trial. Four hundred sixty-three patients received IM injections of 70 to 300 U of NT 201 or BOTOX and were followed up over 16 weeks. The study clearly shows that NT 201 is at least as effective and safe as BOTOX.
引用
收藏
页码：1949 / 1951
页数：3
相关论文
共 50 条
  • [31] Analgesic effect of botulinum toxin type A in Cervical Dystonia
    Couto, M.
    Ferreira, J. J.
    Coelho, M.
    Rosa, M. M.
    Sousa, A. T.
    Noronha, A.
    Sampaio, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 68 - 68
  • [32] Botulinum toxin for cervical dystonia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1109): : 63 - 64
  • [33] Botulinum toxin type A versus anticholinergics for cervical dystonia
    Rodrigues, F. B.
    Duarte, G. S.
    Castelao, M.
    Marques, R. E.
    Ferreira, J.
    Sampaio, C.
    Moore, A. P.
    Costa, J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (04):
  • [34] Efficacy of NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) in the Treatment of Patients with Focal Dystonia
    Grafe, Susanne
    Hanschmann, Angelika
    NEUROLOGY, 2010, 74 (09) : A87 - A87
  • [35] Prevalence of headache attributed to craniocervical dystonia in patients with cervical dystonia and treatment with botulinum toxin type a
    Molho, Eric
    Lipton, Richard
    Bigal, Marcelo
    Gollomp, Stephen
    Felix, Carlos
    VanDenburgh, Amanda
    Brin, Mitchell
    NEUROLOGY, 2007, 68 (12) : A368 - A368
  • [36] Reductions in frequency and intensity of pain with botulinum toxin type a for the treatment of cervical dystonia
    Shah, M., V
    Carlton, R.
    Bramley, T.
    VALUE IN HEALTH, 2008, 11 (03) : A148 - A148
  • [37] Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A
    Brashear, A
    Bergan, K
    Wojcieszek, J
    Siemers, ER
    Ambrosius, W
    MOVEMENT DISORDERS, 2000, 15 (01) : 150 - 153
  • [38] Improvements in quality of life following treatment with botulinum toxin type a for cervical dystonia
    Carlton, R.
    Bramley, T.
    Shah, M., V
    Hansen, J. E.
    VALUE IN HEALTH, 2008, 11 (03) : A145 - A145
  • [39] ELECTROMYOGRAPHIC GUIDANCE OF BOTULINUM TOXIN TREATMENT IN CERVICAL DYSTONIA
    DUBINSKY, RM
    GRAY, CS
    VETEREOVERFIELD, B
    KOLLER, WC
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (03) : 262 - 267
  • [40] Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment
    Ferreira Camargo, Carlos Henrique
    Cattai, Ligia
    Ghizoni Teive, Helio Afonso
    TOXINS, 2015, 7 (06) : 2321 - 2335
12345